Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

FeiFei Qi

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Protein & Cell|August 24, 2024
Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumoniaMingya Liu, Feifei Qi, Jue Wang, et al.
Cell Research|April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Meiqin Liu, Chao Wang, et al.
EMBO Reports|May 23, 2025
Dynamic SAS-6 phosphorylation aids centrosome duplication and elimination in C. elegans oogenesisFeifei Qi, Shanshan Yin, Xiangrui Yang, et al.
Cell Death and Differentiation|June 23, 2026
USP21-mediated deubiquitylation stimulates NuMA recruitment to the cell cortex to promote mitotic spindle orientationMingzheng Hu, Huixian Ma, Runa Wang, et al.
Molecular Therapy Oncolytics|October 26, 2019
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's LymphomaZhitao Ying, Ting He, Xiaopei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2019
Compartmentalized biosynthesis of mycophenolic acidWei Zhang, Lei Du, Zepeng Qu, et al.
Science China. Life Sciences|June 13, 2022
Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71Zhe Chen, Linlin Bao, Bin Zhu, et al.
Cell Death Discovery|March 6, 2026
ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapyZhenjun Li, Liangcheng Lv, Xiaoyu Yao, et al.
BMC Infectious Diseases|October 2, 2024
Study of the driving factors of the abnormal influenza A (H3N2) epidemic in 2022 and early predictions in Xiamen, ChinaHansong Zhu, Feifei Qi, Xiaoying Wang, et al.
BMC Infectious Diseases|November 2, 2024
Correction: Study of the driving factors of the abnormal influenza A (H3N2) epidemic in 2022 and early predictions in Xiamen, ChinaHansong Zhu, Feifei Qi, Xiaoying Wang, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Protein & Cell|August 24, 2024
Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumoniaMingya Liu, Feifei Qi, Jue Wang, et al.
Cell Research|April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Meiqin Liu, Chao Wang, et al.
EMBO Reports|May 23, 2025
Dynamic SAS-6 phosphorylation aids centrosome duplication and elimination in C. elegans oogenesisFeifei Qi, Shanshan Yin, Xiangrui Yang, et al.
Cell Death and Differentiation|June 23, 2026
USP21-mediated deubiquitylation stimulates NuMA recruitment to the cell cortex to promote mitotic spindle orientationMingzheng Hu, Huixian Ma, Runa Wang, et al.
Molecular Therapy Oncolytics|October 26, 2019
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin's LymphomaZhitao Ying, Ting He, Xiaopei Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2019
Compartmentalized biosynthesis of mycophenolic acidWei Zhang, Lei Du, Zepeng Qu, et al.
Science China. Life Sciences|June 13, 2022
Structural and functional analysis of a potent human neutralizing antibody against enterovirus A71Zhe Chen, Linlin Bao, Bin Zhu, et al.
Cell Death Discovery|March 6, 2026
ITK-targeted immune remodeling enhanced the efficacy of anti-CD19 CAR-T cell therapyZhenjun Li, Liangcheng Lv, Xiaoyu Yao, et al.
BMC Infectious Diseases|October 2, 2024
Study of the driving factors of the abnormal influenza A (H3N2) epidemic in 2022 and early predictions in Xiamen, ChinaHansong Zhu, Feifei Qi, Xiaoying Wang, et al.
BMC Infectious Diseases|November 2, 2024
Correction: Study of the driving factors of the abnormal influenza A (H3N2) epidemic in 2022 and early predictions in Xiamen, ChinaHansong Zhu, Feifei Qi, Xiaoying Wang, et al.
Pageof 11